论文信息 - study patients with relapsed systemic AL amyloidosis: results of a phase 1/2 Efficacy and safety of once-weekly and twice-weekly bortezomib in - 字舞流文

study patients with relapsed systemic AL amyloidosis: results of a phase 1/2 Efficacy and safety of once-weekly and twice-weekly bortezomib in

D. Esseltine | D. Reece | G. Merlini | U. Hegenbart | G. Palladini | V. Sanchorawala | J. Fermand | Kevin X. Liu | A. Cakana | H. Hassoun | R. Vescio | L. Heffner | H. Velde